Inventor
Jonathan A. Pachter
Inventor
Setauket, NY, US
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes28%
C07DHeterocyclic compounds14%
C07KPeptides14%
C12NMicroorganisms or enzymes10%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
PatentTitleYear
10,532,056Therapeutic compositions, combinations, and methods of use202010,406,158Methods and compositions for treating abnormal cell growth20199,962,385Methods and compositions for treating abnormal cell growth20188,173,779'Neutralizing human anti-IGFR antibody'20128,017,735'Anti-IGFR1 antibody therapeutic combinations'20117,998,688'Inhibition of EMT induction in tumor cells by anti-cancer agents'20117,851,181'Neutralizing human anti-IGFR antibody'20107,847,068'Neutralizing human anti-IGFR antibody'20107,811,562'Biomarkers for pre-selection of patients for anti-IGF1R therapy'20107,790,474'p53 modulators'20107,667,021'Neutralizing human anti-IGFR antibody'20107,485,645'17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases'20097,432,268'17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases'20087,271,175'17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases'20077,217,796'Neutralizing human anti-IGFR antibody'20077,138,396'17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases'20067,053,091'17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases'20066,903,102'17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases'20056,710,037'Method of treating androgen-dependent disorders'20046,569,872'Use of neurokinin receptor antagonists to treat androgen-dependent diseases'20035,461,057'Hydro-ethano-indeno-pyridines'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–2012Patents assigned to SCHERING CORP (17)· patent assignee history
1995–2012Based in Maplewood, NJ, US· patent location history
2006–2011Based in Chatham, NJ, US· patent location history
2009–2011Based in Setauket, NY, US· patent location history
2012Patents assigned to BRAMS PETER (1)· patent assignee history
2012Patents assigned to FEINGERSH DIANE (1)· patent assignee history
2012Patents assigned to GREENBERG ROBERT (1)· patent assignee history
2018–2020Patents assigned to VERASTEM INC (3)· patent assignee history
2018–2020Based in Wayland, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SCHERING CORP | 17 | 1995–2012 |
| VERASTEM INC | 3 | 2018–2020 |
| BRAMS PETER | 1 | 2012 |
| FEINGERSH DIANE | 1 | 2012 |
| GREENBERG ROBERT | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Setauket, New York, US | 7 | 2009–2011 |
| Maplewood, New Jersey, US | 6 | 1995–2012 |
| Chatham, New Jersey, US | 5 | 2006–2011 |
| Wayland, Massachusetts, US | 3 | 2018–2020 |